Miromatrix Competitors

Delisted . USA . 
Stock . Miromatrix Medical
Miromatrix Medical competes with Anebulo Pharmaceuticals, Pmv Pharmaceuticals, Molecular Partners, Mineralys Therapeutics,, and AN2 Therapeutics; as well as few others. The company conducts business under Biotechnology sector and is part of Health Care industry. Analyzing Miromatrix Medical competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Miromatrix Medical to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Miromatrix Medical competition on your existing holdings.
  
Specify up to 10 symbols:
Hype
Prediction
LowEstimatedHigh
0.000.000.00
Details
Intrinsic
Valuation
LowRealHigh
0.000.000.00
Details

Miromatrix Medical Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Miromatrix Medical and its competitors represents the degree of relationship between the price movements of corresponding delisted stocks. A correlation of about +1.0 implies that the price of Miromatrix and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Miromatrix Medical does not affect the price movement of the other competitor.
Click cells to compare fundamentals   Check Volatility   Backtest Portfolio
High positive correlations   
ANTX
+ 0.83
MLYS
PHVS
+ 0.69
PMVP
MOLN
+ 0.57
PMVP
PEPG
+ 0.57
ANTX
PHVS
+ 0.55
MOLN
NGENF
+ 0.51
PMVP
  
High negative correlations   
PHVS
- 0.65
BNOX
MLYS
- 0.63
MOLN
BNOX
- 0.58
PMVP
NGENF
- 0.56
BNOX
MOLN
- 0.49
BNOX
ANTX
- 0.3
MOLN

Risk-Adjusted Indicators

There is a big difference between Miromatrix Stock performing well and Miromatrix Medical Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Miromatrix Medical's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
ANEB  5.66  0.65  0.11  0.50  5.59 
(8.10)
 19.58 
(10.43)
 48.29 
PMVP  1.85 (0.29) 0.00 (0.34) 0.00 
 0.00 
 4.41 
(3.31)
 16.42 
ZIVO  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
 0.00 
 0.00 
BNOX  7.11  1.33  0.16  0.85  7.14 
(8.71)
 12.06 
(9.80)
 150.97 
MOLN  2.71 (0.34) 0.00 (0.21) 0.00 
 0.00 
 7.84 
(7.39)
 20.58 
MLYS  4.32  0.58  0.14 (0.37) 4.32 
(5.06)
 10.04 
(8.23)
 50.53 
ANTX  2.36  0.23  0.09  0.34  2.30 
(2.99)
 5.41 
(3.85)
 17.09 
PHVS  2.21 (0.24) 0.00  4.97  0.00 
 0.00 
 5.21 
(3.86)
 14.29 
PEPG  8.32 (0.55) 0.00 (0.24) 0.00 
 0.00 
 19.62 
(13.91)
 92.48 
NGENF  2.17  0.02  0.02 (0.09) 2.46 
(3.02)
 4.95 
(3.96)
 32.23 
All Fundamental Data

Miromatrix Medical Competitive Analysis

The better you understand Miromatrix Medical competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Miromatrix Medical's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Miromatrix Medical's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
ANEB PMVP BNOX MOLN MLYS ANTX PHVS PEPG NGENF ACRV
 3.16 
 1.53 
Anebulo
 2.42 
 1.21 
Pmv
 1.41 
 4.88 
Bionomics
 0.51 
 3.88 
Molecular
 3.77 
 16.78 
Mineralys
 0.66 
 1.50 
AN2
 1.42 
 15.25 
Pharvaris
 11.18 
 1.51 
PepGen
 2.16 
 1.81 
NervGen
 3.92 
 5.39 
Acrivon
Market Volatility
(90 Days Market Risk)
Dangerous
Unstable
Very risky
Moderately volatile
Somewhat reliable
Very risky
Not too volatile
Dangerous
Unstable
Slightly risky
Market Performance
(90 Days Performance)
Weak
Very Weak
Modest
Very Weak
Modest
Modest
Very Weak
Very Weak
Very Weak
Very Weak
Odds of Financial Distress
(Probability Of Bankruptcy)
Low
Low
Dangerous
Low
Low
Above Average
About Average
Very High
Quite High
Low
Current Valuation
(Equity Enterprise Value)
Under Valued
Under Valued
Over Valued
Under Valued
Under Valued
Under Valued
Under Valued
Under Valued
Over Valued
Under Valued
Buy or Sell Advice
(Average Analysts Consensus)
Strong Buy
Strong Buy
Not Available
Strong Buy
Strong Buy
Hold
Strong Buy
Strong Buy
Not Available
Strong Buy
Trade Advice
(90 Days Macroaxis Advice)
Sell
Cautious Hold
Not Rated
Strong Sell
Strong Sell
Strong Buy
Cautious Hold
Strong Sell
Strong Sell
Strong Sell
Current Ratio
30.4
24.76
12.46
14.37
N/A
28.17
12.85
11.01
4.25
N/A
Net Asset
4.07 M
191.29 M
27.65 M
158.53 M
205.9 M
138.74 M
398.69 M
150.88 M
17.9 M
138.26 M
EBITDA
(8.05 M)
(85.45 M)
(9.84 M)
(51.65 M)
(192.4 M)
4.9 M
(96.85 M)
(96.23 M)
(11.33 M)
(59.85 M)
Operating Margin
N/A
N/A
89.1
-12.32
N/A
N/A
N/A
N/A
N/A
N/A
Current Valuation
49.92 M
(103.87 M)
14.16 B
(30.99 M)
817.27 M
(51.62 M)
507.28 M
(43.5 M)
48.78 M
(17.17 M)
Price To Book
4.34
0.37
829.81
0.9
5.31
0.5
2.6
0.49
5.13
0.84
Retained Earnings
(65.4 M)
(368.71 M)
(177.98 M)
(246.29 M)
(302.52 M)
(154.46 M)
(265.92 M)
(271.46 M)
N/A
(116.42 M)
Current Asset
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Beta
-1.01
1.45
-0.069
0.63
1.51
0.14
-3.01
0.98
1.7
0.86
Number Of Employees
2
47
8
158
51
41
92
81
4
58
Shares Outstanding
25.93 M
51.93 M
1.63 M
36.87 M
62.8 M
29.88 M
54.23 M
32.69 M
58.68 M
31.14 M
Cash Flow From Operations
(8.09 M)
(51.28 M)
(14.68 M)
(59.25 M)
(166.31 M)
(53.29 M)
(93.05 M)
(82.37 M)
(8.27 M)
(42.64 M)
Annual Yield
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Debt
260.58 K
1.19 M
272.74 K
2.44 M
14.65 M
14.04 M
238.91 K
18.66 M
324.69 K
4.64 M
Return On Equity
-1.14
-0.29
-0.78
-0.34
-0.82
-0.54
-0.59
-0.79
-1.42
-0.46
Z Score
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Return On Asset
-0.66
-0.24
-0.4
-0.21
-0.53
-0.32
-0.33
-0.42
-0.67
-0.29
Number Of Shares Shorted
66.89 K
864.66 K
400.4 K
42.6 K
1.75 M
78.58 K
390.94 K
852.55 K
N/A
1.13 M
Book Value Per Share
0.15
3.39
1.32
3.84
3.84
2.94
5.47
3.64
0.31
6.33
Current Liabilities
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Asset
4.07 M
191.29 M
27.65 M
158.53 M
205.9 M
138.74 M
398.69 M
150.88 M
17.9 M
138.26 M
Debt To Equity
N/A
0.045
0.012
0.02
N/A
N/A
0.001
N/A
0.032
N/A
Short Ratio
1.94
8.38
0.13
26.8
5.94
0.75
12.96
0.41
N/A
10.14
Target Price
6.0
5.8
9.58
10.6
38.29
2.67
36.68
12.2
N/A
21.57
Shares Owned By Institutions
28.18
81.36
16.22
9.72
87.07
46.3
89.4
99.62
N/A
74.97
Market Capitalization
42.79 M
64.4 M
4.95 M
143.88 M
1.02 B
45.12 M
838.99 M
55.58 M
87.43 M
174.67 M
Price To Earnings To Growth
N/A
-0.31
N/A
N/A
N/A
N/A
-0.12
N/A
N/A
N/A
Price To Earning
N/A
N/A
N/A
1.85
N/A
3.96
N/A
N/A
N/A
N/A
Price To Sales
N/A
N/A
386.72
28.95
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
(8.2 M)
(58.71 M)
(15.49 M)
(54.04 M)
(177.81 M)
(64.73 M)
(99.83 M)
(89.98 M)
(12.73 M)
(60.39 M)
Earnings Per Share
-0.32
-1.14
-14.32
-1.79
-3.66
-1.99
-2.83
-2.85
-0.28
-2.66
Shares Owned By Insiders
64.22
2.48
33.91
N/A
2.0
22.5
9.49
0.38
25.27
22.06
Revenue
N/A
N/A
20 K
4.97 M
N/A
N/A
N/A
N/A
N/A
N/A
Working Capital
3.25 M
161.29 M
9.36 M
143.5 M
190.71 M
96.46 M
383.25 M
107.06 M
N/A
116.39 M
Cash And Equivalents
14.55 M
277.43 M
33.56 M
267.13 M
N/A
113.39 M
201.38 M
218.82 M
11.65 M
N/A
Cash Per Share
0.62
6.08
4.46
8.22
N/A
5.84
5.96
9.26
0.2
N/A
Gross Profit
N/A
N/A
(18.96 M)
(42.53 M)
N/A
N/A
N/A
N/A
N/A
N/A
Day Typical Price
1.62
1.21
4.98
3.88
16.71
1.5
15.35
1.55
1.83
5.45
Accumulation Distribution
10203.75
8465.4
0.0802
N/A
62777.33
N/A
697.34
0.0736
2038.3
2181.81
Market Facilitation Index
0.0
0.0
0.42
N/A
0.0
N/A
0.0
0.12
0.0
0.0
Daily Balance Of Power
(0.19)
(0.33)
(0.17)
(9,223,372,036,855)
0.7625
(9,223,372,036,855)
(0.37)
(1.58)
(0.50)
(0.81)
Period Momentum Indicator
(0.05)
(0.03)
(0.07)
(0.02)
0.61
(0.01)
(0.22)
(0.19)
(0.04)
(0.22)
Rate Of Daily Change
0.97
0.98
0.99
0.99
1.04
0.99
0.99
0.89
0.98
0.96
Day Median Price
1.67
1.21
5.03
3.88
16.68
1.5
15.4
1.57
1.84
5.49
Price Action Indicator
(0.16)
(0.01)
(0.19)
(0.01)
0.41
(0.01)
(0.26)
(0.15)
(0.05)
(0.21)
Relative Strength Index
67.84
42.89
60.4
39.79
69.7
67.58
45.97
46.14
42.32
48.59
Coefficient Of Variation
1352.34
(802.86)
1275.72
(1,018)
1086.71
1425.55
(1,274)
(2,239)
10694.84
(3,111)
Mean Deviation
5.66
1.85
7.11
2.71
4.32
2.36
2.21
8.32
2.17
4.19
Jensen Alpha
0.6532
(0.29)
1.33
(0.34)
0.5825
0.2272
(0.24)
(0.55)
0.0169
(0.13)
Total Risk Alpha
0.9473
(0.22)
1.94
(0.24)
0.9335
0.3295
(0.12)
(0.07)
0.2006
0.0368
Sortino Ratio
0.1054
N/A
0.1615
N/A
0.1407
0.0927
N/A
N/A
0.0244
N/A
Downside Variance
37.48
N/A
66.41
N/A
23.51
6.8
N/A
N/A
7.32
N/A
Standard Deviation
8.37
2.53
16.45
4.04
7.12
3.07
2.92
14.26
4.23
5.64
Kurtosis
3.34
3.22
40.2
1.71
17.26
1.79
0.4314
11.34
25.77
1.54
Potential Upside
19.58
4.41
12.06
7.84
10.04
5.41
5.21
19.62
4.95
10.17
Treynor Ratio
0.5019
(0.34)
0.8505
(0.21)
(0.37)
0.3439
4.97
(0.24)
(0.09)
(0.11)
Maximum Drawdown
48.29
16.42
150.97
20.58
50.53
17.09
14.29
92.48
32.23
30.57
Variance
70.05
6.41
270.6
16.35
50.74
9.43
8.51
203.46
17.89
31.78
Market Risk Adjusted Performance
0.5119
(0.33)
0.8605
(0.20)
(0.36)
0.3539
4.98
(0.23)
(0.08)
(0.1)
Risk Adjusted Performance
0.0757
(0.11)
0.0802
(0.08)
0.0918
0.0704
(0.06)
(0.03)
0.0163
(0.02)
Skewness
1.38
(0.30)
5.56
0.1517
3.01
0.962
0.5016
2.86
4.07
0.7027
Semi Deviation
5.59
N/A
7.14
N/A
4.32
2.3
N/A
N/A
2.46
N/A
Information Ratio
0.0771
(0.11)
0.08
(0.09)
0.0957
0.0788
(0.07)
(0.04)
0.0156
(0.03)
Value At Risk
(10.43)
(3.31)
(9.80)
(7.39)
(8.23)
(3.85)
(3.86)
(13.91)
(3.96)
(8.24)
Expected Short fall
(8.10)
N/A
(8.71)
N/A
(5.06)
(2.99)
N/A
N/A
(3.02)
N/A
Downside Deviation
6.12
N/A
8.15
N/A
4.85
2.61
N/A
N/A
2.71
N/A
Semi Variance
31.22
N/A
50.98
N/A
18.64
5.3
N/A
N/A
6.03
N/A

Miromatrix Medical Competition Performance Charts

JavaScript chart by amCharts 3.21.152025FebMarFeb 13Feb 18Feb 23Feb 28MarMar 10Mar 15Mar 20Mar 250%50%100%150% Show all
JavaScript chart by amCharts 3.21.15Anebulo Pharmaceuticals Pmv Pharmaceuticals Bionomics ADR Molecular Partners Mineralys Therapeutics, AN2 Therapeutics Pharvaris BV PepGen Dow Jones Industrial

Five steps to successful analysis of Miromatrix Medical Competition

Miromatrix Medical's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Miromatrix Medical in relation to its competition. Miromatrix Medical's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Miromatrix Medical in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Miromatrix Medical's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Miromatrix Medical, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Miromatrix Medical position

In addition to having Miromatrix Medical in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Macroaxis Index Thematic Idea Now

Macroaxis Index
Macroaxis Index Theme
An experimental equal-weighted index theme of selected equities generated based on Macroaxis rating and scoring system. The Macroaxis Index theme has 46 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Macroaxis Index Theme or any other thematic opportunities.
View All  Next Launch
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.

Other Consideration for investing in Miromatrix Stock

If you are still planning to invest in Miromatrix Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Miromatrix Medical's history and understand the potential risks before investing.
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing

Trending Assets

HCWB
HCW Biologics
0.30  -0.01  -3.23 
MOLN
Molecular Partners
3.88  -0.02  -0.51 
BNOX
Bionomics ADR
4.88  -0.07  -1.41 
PEPG
PepGen
1.51  -0.19  -11.18 
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY